Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?

Clin Cancer Res. 1999 Sep;5(9):2286-8.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Female
  • Humans
  • Individuality
  • Nucleic Acid Hybridization
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics*
  • Predictive Value of Tests